Skip to content

JBIO JBIO Other operating expenses

Other operating expenses at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$200K
Vera Therapeutics logo
Vera TherapeuticsVERA
$125.13M+119%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$53.7M-2.4%
Vor Biopharma logo
Vor BiopharmaVOR
$35.16M+5.6%
Annexon logo
AnnexonANNX
$46.05M-19.8%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's other operating expenses?
JBIO (JBIO) reported other operating expenses of $43.45M in Q1 2026.
How has JBIO's other operating expenses changed year-over-year?
JBIO's other operating expenses increased by 85.8% year-over-year, from $23.38M to $43.45M.
What is the long-term trend for JBIO's other operating expenses?
Over 4 years (2021 to 2025), JBIO's other operating expenses has grown at a 49.0% compound annual growth rate (CAGR), from $23.02M to $113.54M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.